Predicting Alzheimer's disease subtypes and understanding their molecular characteristics in living patients with transcriptomic trajectory profiling is a research paper published in Alzheimer s & Dementia (2025). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: U01 AG024904
U.S. Department of Defense
Grant: W81XWH‐12‐2‐0012
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5U54AG065181-03
IUSM Alzheimer's Disease Drug Discovery Center
National Institutes of Health
Grant: 1U01AG024904-01
Alzheimers Disease Neuroimaging Initiative
National Institutes of Health
Grant: 5R01NS119280-02
Tau-seed protein interactome and its role in neurodegenerative tauopathies
Indiana University Precision Health Initiative NIH TREAT-AD U54
Grant: 5R01NS119280
NIA NIH HHS
Grant: R21 AG075541
NIA NIH HHS
Grant: U54 AG065181
NINDS NIH HHS
Grant: R01 NS119280
Indiana University Precision Health Initiative NIH TREAT-AD U54
Grant: 5U54AG065181
Department of Defense
Grant: W81XWH-12-2-0012
Alzheimer's Disease Neuroimaging Initiative
Alzheimer's Drug Discovery Foundation
Alzheimer's Association
AbbVie
F. Hoffmann-La Roche Ltd
Elan Pharmaceuticals, Inc.
Eli Lilly and Company
EuroImmun
Biogen
Bristol-Myers Squibb Company
Araclon Biotech
CereSpir, Inc.
BioClinica, Inc.
Cogstate; Eisai Inc.
NIBIB NIH HHS
Fields of Study
MeSH Terms
Keywords